Liposuction risk is documented to an unusual degree for a cosmetic procedure — three large published datasets, several national registries, and dedicated mortality surveys. The catch is that each answers a slightly different question, so quoting one figure in isolation misleads. What follows separates the sources, ranks the complications by published frequency, and sets out the risk multipliers the registry data identified. If you have been weighing up female liposuction for a home around Sarasota, FL, this guide covers how it actually works, what it tends to cost, and where the results usually fall short.
The short version
- Published overall liposuction complication rates diverge widely: 2.62 percent, 12 percent and 1.16 percent across three major datasets.
- Contour irregularity is the most frequently reported complication across pooled datasets, at 2.35 percent and 2 percent.
- A 69,424-patient registry found infusion-assisted liposuction carried 6.7 times the risk of serious complication versus conventional technique.
- Modern pooled data place death at approximately 0.02 percent, against a historical benchmark of 1 in 5,224 procedures.
- Overall complications were 3.7 percent above five litres of aspirate against 1.1 percent below, driven almost entirely by seroma.
The same procedure, four published numbers
| Published dataset | Scope | Overall complication rate reported |
|---|---|---|
| Comerci et al., Aesthetic Surgery Journal 2024 | 39 studies, 29,368 patients, mean BMI 26.36 | 2.62% (95% CI 1.78–3.84) |
| Aljerian et al., Plast Surg (Oakv) | 60 studies, 21,776 patients | 12% (95% CI 8–16) |
| Saad et al., 69,424 patients (national cosmetic registry) | March 2015–December 2022; 93.2% female; average age 43 | 1.16% for liposuction performed alone |
| ASPS TOPS registry analysis | More than 4,500 liposuction patients; average volume about 2 L | 1.5%; major complications fewer than 1 in 1,000; no deaths |
The 2.62% and 12% figures are not in conflict at the level that matters. Both syntheses independently placed contour irregularity at 2% and seroma at 2%, haematoma at 1% and surgical site infection at 1%. The divergence sits in the "any complication" bucket, which absorbs everything from bruising and prolonged induration to a minor pigmentary change. Comerci reports high between-study heterogeneity (I² 80.7% for infection) and notes that it prevented identification of predictive risk factors; Aljerian concludes that "a considerable degree of heterogeneity exists within the examined literature".
The complications, ranked by published frequency
| Complication | Published range | What the sources say about it |
|---|---|---|
| Contour deformity or irregularity | 2.35% (Comerci); 2% (Aljerian) | Most common complication in both analyses; pooled by modality at about 0.12% for ultrasound-assisted versus about 3.36% for suction-assisted |
| Seroma | 0.65% (Comerci); 2% (Aljerian); 3.93% pooled for radiofrequency-assisted | The complication most sensitive to volume: seroma "almost entirely" explains the rise from 1.1% to 3.7% above 5 L aspirate |
| Hyperpigmentation | 1.49% (Comerci); 1% (Aljerian) | Counted as a pigmentary change in the second analysis |
| Haematoma | 0.27% (Comerci); 1% (Aljerian) | Small haematomas are described by ASPS as resolving on their own or with little treatment |
| Fibrosis or induration | 1% (Aljerian) | Grouped with the tissue-firmness changes described in postoperative reviews |
| Infection | 0.020% (Comerci); 1% (Aljerian); 0.54% for infusion-assisted technique (Saad) | Technique-specific rate is the standout number in the 69,424-patient registry analysis |
| Venous thromboembolism | 0.017% (95% CI 0.0060–0.053) | Rare, but reported mortality up to 15% when it occurs |
| Local anaesthetic toxicity | 0.016% (95% CI 0.0040–0.064) | Why ASPS sets a 35 mg/kg lidocaine limit in wetting solutions |
| Death | About 0.02%; historically 1 in 5,224 (19.1 per 100,000) in a 2000 survey | Most commonly attributed to venous thromboembolism |
The risk multipliers the registry data identified
Combined procedures. Registry analysis of 129,007 cosmetic patients reported VTE at 0.20% for combined procedures versus 0.04% for solitary procedures, and assigned body procedures a relative risk of 13.47. A separate analysis using accreditation patient-safety data cites a study in which standardised DVT prophylaxis protocols in body contouring reduced VTE rates from 2.1% to 0.5%.
Technique. The 69,424-patient analysis found infusion-assisted liposuction carried a 6.7-times higher risk of serious complication than conventional liposuction and a 0.54% infection rate, while laser-assisted liposuction had a 50% lower risk. Power-assisted liposuction had the highest rate of major complications, but multivariable regression identified infusion-assisted technique as the highest risk once confounders were controlled. Pooled modality data additionally show radiofrequency-assisted liposuction with the highest seroma (3.93%) and thermal-injury (1.64%) rates, and ultrasound-assisted with the lowest contour-irregularity rate (0.12%).
Patient factors. The same registry analysis reported that diabetes and being underweight correlate with a higher complication risk, and the ASPS registry analysis found larger volumes and higher BMIs among patients who had complications — but also found that higher-BMI patients tolerated larger volumes better than lower-BMI patients, who showed a more exponential increase in risk. ASPS's own patient-facing risk list includes bruising, cannula breakage, persistent change in skin sensation, damage to deeper structures, fluid accumulation, infection, irregular contours or asymmetries, need for revision surgery, poor wound healing, rippling or loose skin, thermal burn from ultrasound-assisted technique, and cardiac or pulmonary complications.
| Risk multiplier | Published magnitude |
|---|---|
| Volume above 5 L aspirate versus below | 3.7% versus 1.1% overall complication rate |
| Combined versus solitary procedures (VTE) | 0.20% versus 0.04%; body procedures relative risk 13.47 |
| Infusion-assisted versus conventional technique | 6.7× higher risk of serious complication |
| Laser-assisted versus conventional technique | 50% lower risk |
| Structured DVT prophylaxis in body contouring | VTE fell from 2.1% to 0.5% |
| Diabetes or low body weight | Correlate with higher complication risk in registry data |
What has changed, and what has not
The mortality picture is worth reading chronologically. A 2000 census survey of cosmetic surgeons put liposuction mortality at 1 in 5,224 procedures — 19.1 per 100,000 — for the late 1990s, and subsequent literature has repeatedly cited that figure as the historical benchmark. Modern pooled data place death at approximately 0.02%, with VTE the leading mechanism, and the ASPS registry analysis of more than 4,500 cases recorded no deaths at all. Registry analyses note that prophylaxis practice, anaesthesia monitoring and technique have all moved.
What has not changed is the structure of the risk. Rare and serious sits at one end — VTE, fat embolism, organ perforation, anaesthetic toxicity — and common and cosmetic sits at the other, with contour irregularity the most frequently reported outcome in every pooled dataset. Between them lie the volume-sensitive complications, seroma chief among them. If your decision hinges on any of these, the useful next step is our surgeon-selection guide (which covers how to interrogate a provider's complication handling) and the Sarasota liposuction FAQ. The pre-consultation checklist lists what to confirm before booking.
How to read a complication rate
Four questions turn a published percentage into something usable. First, what is the denominator — patients, procedures, or treated areas? A rate expressed per treated area is not comparable to one expressed per patient, which is part of why the pooled figures diverge. Second, what counts as a complication? Comerci's 2.62% counts specified events requiring attention; Aljerian's 12% absorbs anything recorded, including bruising and prolonged induration. Third, which technique and volume distribution did the sample actually contain? The 69,424-patient registry found technique changed serious-complication risk by a factor of 6.7, so a pooled rate from mixed techniques describes a distribution, not a procedure.
Fourth, who reported it? Registry and insurance-database data capture events serious enough to generate a claim, which undercounts minor issues, while survey and surgeon-reported data capture minor issues but may over-represent them by recording subjective findings. The literature acknowledges this directly: the registry analysis notes limitations in capturing full demographic and complication detail, and both meta-analyses report heterogeneity high enough to frustrate risk-factor analysis.
The mortality trend, and what changed
The mortality data are best read as a timeline rather than a single number. A 2000 census survey of cosmetic surgeons calculated a mortality rate of 1 in 5,224 procedures for the late 1990s — 19.1 per 100,000 — and identified pulmonary embolism as a leading cause; that figure has been cited in the literature ever since as the historical benchmark. Modern pooled meta-analysis data place death at approximately 0.02%, most commonly attributed to venous thromboembolism, and the ASPS registry analysis of more than 4,500 patients recorded no deaths at all. In the same period, VTE rates in body contouring were reported falling from 2.1% to 0.5% where standardised prophylaxis protocols were used.
Three published changes plausibly sit behind the improvement: prophylaxis protocols, which changed outcomes in the reported studies; the widespread use of tumescent technique with epinephrine, which reduces blood loss; and the formalisation of facility standards, including the 5,000 cc aspirate rule that routes higher-volume cases into monitored settings. What has not changed is where the risk concentrates: combined procedures, larger volumes, body procedures and higher-risk patient profiles.
For anyone weighing this, the published figures support one clear conclusion — the rare catastrophic events are the ones worth asking about directly. Both ASPS and ABPS treat hospital privileges as a standard requirement, and the reasons become obvious once you read the complication data: vascular events, anaesthetic toxicity and fluid problems are the events that need hospital-grade care, and a provider who can name the hospital and the complication protocol has answered the question that matters most. Our surgeon-selection guide walks through how to ask it, and the checklist puts the questions in writing.
Frequently asked questions
What is the most commonly reported complication after liposuction?
Contour deformity or irregularity is the most commonly reported complication, placed at 2.35% in one pooled analysis and 2% in another. Pooled by modality it was about 0.12% for ultrasound-assisted liposuction versus roughly 3.36% for suction-assisted.
Why is there no single liposuction complication rate?
The datasets answer different questions. Published overall rates run 2.62%, 12% and 1.16% across three major datasets, and the divergence sits in the any-complication bucket, which absorbs everything from bruising and prolonged induration to minor pigmentary change. High between-study heterogeneity is reported.
What is the risk of dying from liposuction?
Modern pooled data place death at approximately 0.02%, most commonly attributed to venous thromboembolism, and an ASPS registry analysis of more than 4,500 patients recorded no deaths. A 2000 census survey put the historical rate at 1 in 5,224 procedures, or 19.1 per 100,000.
Sources
Published figures as of the access date (12 Sep 2026).
1. Comerci AJ, et al. Aesthetic Surgery Journal 2024;44(7):NP454–NP463 — https://pubmed.ncbi.nlm.nih.gov/38563572/
2. Aljerian A, et al. Plast Surg (Oakv) 2024;32(1):19–32 — https://pmc.ncbi.nlm.nih.gov/articles/PMC10902471/
3. Saad M, et al. Aesthetic Surgery Journal 2025;45(12):1252–1262 (69,424 patients; 1.16%; 6.7×; 50% lower) — https://doi.org/10.1093/asj/sjaf147
4. ASPS press release, How Much Liposuction Is 'Safe'? The Answer Varies by Body Weight (1.5%; 3.7% vs 1.1%; no deaths; <1 in 1,000 major) — https://www.plasticsurgery.org/news/press-releases/how-much-liposuction-is-safe-the-answer-varies-by-body-weight
5. ASJ Open Forum, QUAD A patient-safety analysis (Winocour 129,007-patient VTE data; prophylaxis 2.1%→0.5%) — https://academic.oup.com/asjopenforum/article/doi/10.1093/asjof/ojaf105/8241937
6. Systematic review of contemporary liposuction techniques (modality-specific pooled rates) — https://frontiersin.org/articles/10.3389/fsurg.2026.1892614/full
7. ASPS, Liposuction Risks and Safety — https://www.plasticsurgery.org/cosmetic-procedures/liposuction/safety
8. ASPS Practice Advisory on Liposuction: Executive Summary (lidocaine 35 mg/kg) — https://www.plasticsurgery.org/documents/medical-professionals/health-policy/key-issues/executive-summary-on-liposuction.pdf
9. Grazer FM, de Jong RH. Plast Reconstr Surg 2000 (1 in 5,224; 19.1 per 100,000) — https://pubmed.ncbi.nlm.nih.gov/10627013/
Medical-safety note: Every rate above is a published population-level figure from a named source and is not a prediction for any individual. Results vary, and personal risk depends on your own health factors. Only a board-certified plastic surgeon who examines you can assess suitability and discuss your specific risks.
